Organization
Brigham and Women’s Hospital, Harvard Medical School, Boston, United States of America
3 abstracts
Abstract
ALTERATIONS OF PERIPHERAL LYMPHOCYTE SUBSETS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THEIR CHANGES AFTER OUR NEW IMMUNOREGULATORY COMBINATION THERAPIESOrg: The Second Hospital of Shanxi Medical University, Rheumatology, Taiyuan, China, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States of America,
Abstract
ABNORMAL STATUSES OF PERIPHERAL CD4+T CELL SUBSETS IN PATIENTS WITH GOUT AND THEIR CHANGES AFTER RECEIVING COMBINED IMMUNOMODULATORY THERAPYOrg: Shanxi Medical University, Taiyuan, China, the Second Hospital of Shanxi Medical University, Taiyuan, China, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States of America,
Abstract
BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND AN INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: 16-WEEK EFFICACY & SAFETY FROM BE COMPLETE, A PHASE 3, MULTICENTRE, RANDOMISED PLACEBO-CONTROLLED STUDYOrg: Brigham and Women’s Hospital, Harvard Medical School, Boston, United States of America, University of Glasgow, Institute of Infection, Immunity and Inflammation, Glasgow, United Kingdom, University of Rochester, Department of Medicine, Rochester, United States of America, University of Washington, Swedish Medical Center and Providence St. Joseph Health, Seattle, United States of America, Amsterdam Rheumatology & Clinical Immunology Center, Department of Clinical Immunology & Rheumatology, Amsterdam, Netherlands,